Dhabali A A H, Awang R, Zyoud S H
WHO Collaborating Centre for Drug Information, National Poison Centre, Universiti Sains Malaysia (USM), Penang, Malaysia.
Int J Clin Pharmacol Ther. 2011 Aug;49(8):500-9. doi: 10.5414/cp201524.
The prescription of contraindicated drugs is a preventable medication error, which can cause morbidity and mortality. Recent data on the factors associated with drug contraindications (DCIs) is limited world-wide, especially in Malaysia.
The objectives of this study are 1) to quantify the prevalence of DCIs in a primary care setting at a Malaysian University; 2) to identify patient characteristics associated with increased DCI episodes, and 3) to identify associated factors for these DCIs.
We retrospectively collected data from 1 academic year using computerized databases at the Universiti Sains Malaysia (USM) from patients of USM's primary care. Descriptive and comparative statistics were used to characterize DCIs.
There were 1,317 DCIs during the study period. These were observed in a cohort of 923 patients, out of a total of 17,288 patients, representing 5,339 DCIs per 100,000 patients, or 5.3% of all patients over a 1-year period. Of the 923 exposed patients, 745 (80.7%) were exposed to 1 DCI event, 92 (10%) to 2 DCI events, 35 (3.8%) to 3 DCI events, 18 (2%) to 4 DCI events, and 33 patients (3.6%) were exposed to 5 or more DCI events. The average age of the exposed patients was 30.7 ± 15 y, and 51.5% were male. Multivariate logistic regression analysis revealed that being male (OR = 1.3; 95% CI = 1.1 - 1.5; p < 0.001), being a member of the staff (OR = 3; 95% CI = 2.5 - 3.7; p < 0.001), having 4 or more prescribers (OR = 2.8; 95% CI = 2.2 - 3.6; p < 0.001), and having 4 or more longterm therapeutic groups (OR = 2.3; 95%CI = 1.7 - 3.1; p < 0.001), were significantly associated with increased chance of exposure to DCIs.
This is the first study in Malaysia that presents data on the prevalence of DCIs. The prescription of contraindicated drugs was found to be frequent in this primary care setting. Exposure to DCI events was associated with specific socio-demographic and health status factors. Further research is needed to evaluate the relationship between health outcomes and the exposure to DCIs.
开具禁忌药物是一种可预防的用药错误,可能导致发病和死亡。目前全球范围内关于药物禁忌(DCIs)相关因素的最新数据有限,在马来西亚尤其如此。
本研究的目的是:1)量化马来西亚一所大学初级保健机构中药物禁忌的发生率;2)确定与药物禁忌事件增加相关的患者特征;3)确定这些药物禁忌的相关因素。
我们使用马来西亚理科大学(USM)的计算机数据库,回顾性收集了该校初级保健机构1个学年的患者数据。采用描述性和比较性统计方法对药物禁忌进行特征描述。
研究期间共出现1317例药物禁忌情况。这些情况出现在923名患者中,而总共有17288名患者,相当于每100000名患者中有5339例药物禁忌情况,即1年期间所有患者的5.3%。在923名暴露患者中,745名(80.7%)经历了1次药物禁忌事件,92名(10%)经历了2次药物禁忌事件,35名(3.8%)经历了3次药物禁忌事件,18名(2%)经历了4次药物禁忌事件,33名患者(3.6%)经历了5次或更多次药物禁忌事件。暴露患者的平均年龄为30.7±15岁,男性占51.5%。多因素逻辑回归分析显示,男性(比值比[OR]=1.3;95%置信区间[CI]=1.1 - 1.5;p<0.001)、工作人员(OR = 3;95% CI = 2.5 - 3.7;p < 0.001)、有4名或更多开处方者(OR = 2.8;95% CI = 2.2 - 3.6;p < 0.001)以及有4个或更多长期治疗组(OR = )2.3;95% CI = 1.7 - 3.1;p < 0.001)与药物禁忌暴露机会增加显著相关。
这是马来西亚第一项提供药物禁忌发生率数据的研究。发现在该初级保健机构中开具禁忌药物的情况很常见。药物禁忌事件的暴露与特定的社会人口统计学和健康状况因素相关。需要进一步研究来评估健康结果与药物禁忌暴露之间的关系。